{
    "nctId": "NCT03541278",
    "briefTitle": "Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique",
    "officialTitle": "A Prospective Multicenter Clinical Trial of Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique for Early Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 350,
    "primaryOutcomeMeasure": "Visualization Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with preoperative pathology confirmed invasive breast cancer;\n* Clinical T1-3 N0-3 M0 (with positive fine-needle aspiration result in their clinical or ultrasonic suspicious axillary lymph node ; no clinical or radiologic evidence of distant metastases);\n* Be able and willing to sign informed consent forms.\n\nExclusion Criteria:\n\n* Patients with enlarged internal mammary nodes by imaging;\n* Patients who have received neoadjuvant therapy (including neoadjuvant chemotherapy and / or endocrine therapy);\n* Patients with a previous history of breast cancer (recurrence of breast cancer and contralateral breast cancer);\n* Patients with a history of other malignancies;\n* Patients who have had previous surgery in axillary or internal mammary;\n* Patients in pregnancy and lactation;\n* Patients participant in other clinical trials that will have an impact on the results of this study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}